MARCO is associated with radiosensitivity in lung cancer through modulation of Hippo signaling
Immunobiology · 2026-09 · 231 (5) · 153232
DOI: 10.1016/j.imbio.2026.153232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunobiology, 2026-09. Verfasst von Zhenfeng Zong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Cangzhou Central Hospital, Cangzhou 061000, Hebei, China. Electronic address: 13315777392@163.com. Hauptthemen laut MEDLINE: Radiation Tolerance, Lung Neoplasms, Protein Serine-Threonine Kinases, Signal Transduction. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Lung cancer remains a significant global health challenge, with radiotherapy serving as a cornerstone of treatment. However, the development of resistance to radiation therapy poses a major hurdle in effective disease management. In this study, we explore the novel role of MARCO, a gene involved in antimicrobial defense and cancer progression, in modulating the radiosensitivity of lung cancer cells.Our analysis of clinical samples demonstrated a significant reduction in MARCO expression in lung cancer patients undergoing radiotherapy. In vitro studies using MARCO-overexpressing and MARCO-knockdown lung cancer cells further revealed that MARCO expression was markedly lower in radioresistant lung cancer tissues compared to non-irradiated counterparts. Functionally, overexpression of MARCO enhanced radiosensitivity, whereas its silencing conferred increased resistance to radiation.Mechanistically, MARCO overexpression elevated γ-H2AX levels and suppressed critical DNA repair proteins, including phosphorylated DNA-PK (p-DNA-PK) and RAD51, indicating that both the non-homologous end joining (NHEJ) and homologous recombination (HR) repair pathways were compromised. Furthermore, MARCO overexpression augmented radiation-induced apoptosis-related marker expression, while MARCO silencing diminished these responses. Further investigations identified MARCO as a regulator of the Hippo/YAP signaling pathway. MARCO overexpression inhibited Hippo/YAP signaling and promoted YAP phosphorylation, a key determinant of cell survival and proliferation. In vivo, MARCO silencing resulted in larger tumor volumes and increased Ki67 expression, whereas MARCO overexpression sensitized tumors to radiation and reduced p-YAP levels. Additionally, xenograft models confirmed the radiosensitizing effect of MARCO, as MARCO-knockout tumors exhibited enhanced resistance to radiation therapy, accompanied by increased proliferation and Hippo/YAP pathway activation. These findings establish MARCO as a potential therapeutic target for overcoming radioresistance in lung cancer, offering new insights into strategies to enhance treatment efficacy in patients with advanced disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Cangzhou Central Hospital, Cangzhou 061000, Hebei, China. Electronic address: 13315777392@163.com.
- Department of Thoracic Surgery, Cangzhou Central Hospital, Cangzhou 061000, Hebei, China.
- Department of Respiratory Medicine, HejianPeople's Hospital, Cangzhou 061000, Hebei, China.
Zitieren
APA
Zong, Z., Tang, G., Yu, G., & Kong, F. (2026). MARCO is associated with radiosensitivity in lung cancer through modulation of Hippo signaling. Immunobiology, 231(5), 153232. https://doi.org/10.1016/j.imbio.2026.153232
Vancouver
Zong Z, Tang G, Yu G, Kong F. MARCO is associated with radiosensitivity in lung cancer through modulation of Hippo signaling. Immunobiology. 2026;231(5):153232. doi:10.1016/j.imbio.2026.153232
BibTeX
@article{Zong2026,
author = {Zong, Zhenfeng and Tang, Guojie and Yu, Guo and Kong, Fanyi},
title = {MARCO is associated with radiosensitivity in lung cancer through modulation of Hippo signaling},
journal = {Immunobiology},
year = {2026},
volume = {231},
number = {5},
pages = {153232},
doi = {10.1016/j.imbio.2026.153232}
}
EUVIMED